Safety aspects of next generation probiotics

Maria Saarela

Research output: Contribution to journalArticleScientificpeer-review

Abstract

Advanced knowledge about the importance of gut microbiota for human health has increased the interest towards using new bacteria — besides the traditionally used lactobacilli and bifidobacteria — as probiotics. Currently candidates for next generation probiotics (NGP) have been searched amongst the gut bacteria that are associated with health, including strains from the genera Bacteroides, Clostridium, Faecalibacterium and Akkermansia. Unlike Lactobacillus spp. and Bifidobacterium spp., NGP, especially Bacteroides spp. and Clostridium spp., seem to be more ambivalent regarding their potential to cause infectious diseases. Therefore thorough safety assessment of NGP strains is vital. One important aspect of the safety assessment, which is sometimes ignored, is the potential to carry and spread antibiotic resistance genes. Because of the technological challenges in the production and formulation of many NGP species, it is likely that these will mainly be sold as supplements. The suitability and safety of novel probiotics to target consumer groups and conditions need to be carefully selected to ensure that the health promoting effects can be obtained.
Original languageEnglish
Pages (from-to)8-13
Number of pages6
JournalCurrent Opinion in Food Science
Volume30
DOIs
Publication statusAccepted/In press - 2019
MoE publication typeNot Eligible

Fingerprint

Probiotics
probiotics
Safety
Bacteroides
Bifidobacterium
safety assessment
Clostridium
Lactobacillus
Health
Bacteria
health promotion
bacteria
Microbial Drug Resistance
intestinal microorganisms
antibiotic resistance
infectious diseases
Communicable Diseases
human health
digestive system
Genes

Cite this

Saarela, Maria. / Safety aspects of next generation probiotics. In: Current Opinion in Food Science. 2019 ; Vol. 30. pp. 8-13.
@article{89f6386f514f43c7ba0755cd163f8d2b,
title = "Safety aspects of next generation probiotics",
abstract = "Advanced knowledge about the importance of gut microbiota for human health has increased the interest towards using new bacteria — besides the traditionally used lactobacilli and bifidobacteria — as probiotics. Currently candidates for next generation probiotics (NGP) have been searched amongst the gut bacteria that are associated with health, including strains from the genera Bacteroides, Clostridium, Faecalibacterium and Akkermansia. Unlike Lactobacillus spp. and Bifidobacterium spp., NGP, especially Bacteroides spp. and Clostridium spp., seem to be more ambivalent regarding their potential to cause infectious diseases. Therefore thorough safety assessment of NGP strains is vital. One important aspect of the safety assessment, which is sometimes ignored, is the potential to carry and spread antibiotic resistance genes. Because of the technological challenges in the production and formulation of many NGP species, it is likely that these will mainly be sold as supplements. The suitability and safety of novel probiotics to target consumer groups and conditions need to be carefully selected to ensure that the health promoting effects can be obtained.",
author = "Maria Saarela",
year = "2019",
doi = "10.1016/j.cofs.2018.09.001",
language = "English",
volume = "30",
pages = "8--13",
journal = "Current Opinion in Food Science",
issn = "2214-7993",
publisher = "Elsevier",

}

Safety aspects of next generation probiotics. / Saarela, Maria.

In: Current Opinion in Food Science, Vol. 30, 01.12.2019, p. 8-13.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Safety aspects of next generation probiotics

AU - Saarela, Maria

PY - 2019

Y1 - 2019

N2 - Advanced knowledge about the importance of gut microbiota for human health has increased the interest towards using new bacteria — besides the traditionally used lactobacilli and bifidobacteria — as probiotics. Currently candidates for next generation probiotics (NGP) have been searched amongst the gut bacteria that are associated with health, including strains from the genera Bacteroides, Clostridium, Faecalibacterium and Akkermansia. Unlike Lactobacillus spp. and Bifidobacterium spp., NGP, especially Bacteroides spp. and Clostridium spp., seem to be more ambivalent regarding their potential to cause infectious diseases. Therefore thorough safety assessment of NGP strains is vital. One important aspect of the safety assessment, which is sometimes ignored, is the potential to carry and spread antibiotic resistance genes. Because of the technological challenges in the production and formulation of many NGP species, it is likely that these will mainly be sold as supplements. The suitability and safety of novel probiotics to target consumer groups and conditions need to be carefully selected to ensure that the health promoting effects can be obtained.

AB - Advanced knowledge about the importance of gut microbiota for human health has increased the interest towards using new bacteria — besides the traditionally used lactobacilli and bifidobacteria — as probiotics. Currently candidates for next generation probiotics (NGP) have been searched amongst the gut bacteria that are associated with health, including strains from the genera Bacteroides, Clostridium, Faecalibacterium and Akkermansia. Unlike Lactobacillus spp. and Bifidobacterium spp., NGP, especially Bacteroides spp. and Clostridium spp., seem to be more ambivalent regarding their potential to cause infectious diseases. Therefore thorough safety assessment of NGP strains is vital. One important aspect of the safety assessment, which is sometimes ignored, is the potential to carry and spread antibiotic resistance genes. Because of the technological challenges in the production and formulation of many NGP species, it is likely that these will mainly be sold as supplements. The suitability and safety of novel probiotics to target consumer groups and conditions need to be carefully selected to ensure that the health promoting effects can be obtained.

UR - http://www.scopus.com/inward/record.url?scp=85056155849&partnerID=8YFLogxK

U2 - 10.1016/j.cofs.2018.09.001

DO - 10.1016/j.cofs.2018.09.001

M3 - Article

VL - 30

SP - 8

EP - 13

JO - Current Opinion in Food Science

JF - Current Opinion in Food Science

SN - 2214-7993

ER -